NL190631B - Farmaceutisch preparaat met antibacteriele werking dat amoxycilline en een zout van clavulanzuur bevat. - Google Patents
Farmaceutisch preparaat met antibacteriele werking dat amoxycilline en een zout van clavulanzuur bevat.Info
- Publication number
- NL190631B NL190631B NLAANVRAGE7810176,A NL7810176A NL190631B NL 190631 B NL190631 B NL 190631B NL 7810176 A NL7810176 A NL 7810176A NL 190631 B NL190631 B NL 190631B
- Authority
- NL
- Netherlands
- Prior art keywords
- salt
- pharmaceutical preparation
- antibacterial action
- clavulanic acid
- action containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4219177 | 1977-10-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
NL7810176A NL7810176A (nl) | 1979-04-17 |
NL190631B true NL190631B (nl) | 1994-01-03 |
Family
ID=10423254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7810176,A NL190631B (nl) | 1977-10-11 | 1978-10-10 | Farmaceutisch preparaat met antibacteriele werking dat amoxycilline en een zout van clavulanzuur bevat. |
Country Status (24)
Country | Link |
---|---|
US (2) | US4441609A (nl) |
JP (1) | JPS5476831A (nl) |
AU (1) | AU525089B2 (nl) |
BE (1) | BE870988A (nl) |
CA (1) | CA1105385A (nl) |
CH (1) | CH642258A5 (nl) |
DE (1) | DE2843318A1 (nl) |
FR (1) | FR2405711A1 (nl) |
GB (1) | GB2005538B (nl) |
HK (1) | HK73785A (nl) |
IE (1) | IE47450B1 (nl) |
IL (1) | IL55660A (nl) |
IT (1) | IT1109273B (nl) |
JO (1) | JO984B1 (nl) |
KE (1) | KE3525A (nl) |
MT (1) | MTP836B (nl) |
MY (1) | MY8500996A (nl) |
NL (1) | NL190631B (nl) |
NZ (1) | NZ188497A (nl) |
PL (1) | PL210174A1 (nl) |
PT (1) | PT68600A (nl) |
SE (2) | SE435899B (nl) |
SG (1) | SG34985G (nl) |
ZA (1) | ZA785682B (nl) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE41109B1 (en) * | 1974-04-20 | 1979-10-24 | Beecham Group Ltd | Novel -lactam antibiotic from streptomyces clavuligerus |
AT353409B (de) * | 1975-02-07 | 1979-11-12 | Glaxo Lab Ltd | Verfahren zum entfernen von verunreinigungen aus clavulansaeure oder deren salzen |
EP0008905B1 (en) * | 1978-09-06 | 1983-02-16 | Beecham Group Plc | Pharmaceutical compositions containing two beta-lactam derivatives |
NZ194912A (en) | 1979-10-02 | 1983-05-31 | Beecham Group Ltd | 6 -(2-(2'-methylphenoxycarbonyl)-2-thien-3'-ylacetamido)-penicillanic acid and pharmaceutical compositions |
NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
US4406887A (en) * | 1981-10-13 | 1983-09-27 | Bristol-Myers Company | Method for treating resistant bacteria including anaerobes |
EP0080862B1 (en) * | 1981-12-02 | 1985-09-25 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
US5743398A (en) * | 1984-05-22 | 1998-04-28 | Southpac Trust International, Inc. | Floral wrapper utilizing a breathable packaging material |
FR2593152B1 (fr) * | 1986-01-22 | 1988-12-23 | Adir | Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles. |
EP0273209B1 (en) * | 1986-12-30 | 1992-01-15 | American Cyanamid Company | Composition of matter containing polycarbophil |
GB9007143D0 (en) * | 1990-03-30 | 1990-05-30 | Beecham Group Plc | Veterinary composition |
US5814337A (en) * | 1992-10-07 | 1998-09-29 | Beecham Group Plc | Pharmaceutical formulation |
GB9009446D0 (en) * | 1990-04-26 | 1990-06-20 | Beecham Group Plc | Veterinary composition |
US5643902A (en) * | 1990-04-26 | 1997-07-01 | Pfizer Inc. | Veterinary treatment |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
US5861172A (en) * | 1991-05-08 | 1999-01-19 | Laboratorios Beecham Sa | Pharmaceutical formulations of compacted granulates of β-lactam antibiotics |
GB9201639D0 (en) * | 1992-01-25 | 1992-03-11 | Smithkline Beecham Plc | Pharmaceutical formulations |
GB9408117D0 (en) * | 1994-04-23 | 1994-06-15 | Smithkline Beecham Corp | Pharmaceutical formulations |
GB9411626D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Package |
US5947274A (en) * | 1994-08-05 | 1999-09-07 | Smithkline Beecham P.L.C. | Desiccating container for moisture-sensitive material |
GB9416599D0 (en) * | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
DZ2028A1 (fr) | 1995-05-03 | 2002-10-23 | Smithkline Beecham Plc | Médicaments destinés au traitement d'infections bactériennes en pédiatrie. |
US20030109503A1 (en) * | 1995-06-06 | 2003-06-12 | Smithkline Beecham P.L.C. | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
KR100495585B1 (ko) | 1995-09-07 | 2005-09-09 | 스미스클라인비이참피이엘시이 | 제약 제제 |
AT403375B (de) * | 1995-11-15 | 1998-01-26 | Biochemie Gmbh | Verfahren zur fällung von alkalisalzen der clavulansäure |
ITMI952354A1 (it) * | 1995-11-16 | 1997-05-16 | Smithkline Beecham Spa | Composizione farmaceutica |
TWI225402B (en) | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
AT407214B (de) * | 1996-03-13 | 2001-01-25 | Biochemie Gmbh | Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika |
AT407701B (de) * | 1996-08-12 | 2001-05-25 | Biochemie Gmbh | Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung |
US6112888A (en) * | 1996-06-28 | 2000-09-05 | W. R. Grace & Co.-Conn. | Non-reclosable packages containing desiccant matrix |
US6180708B1 (en) | 1996-06-28 | 2001-01-30 | W. R. Grace & Co.-Conn. | Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions |
GB9616536D0 (en) | 1996-08-06 | 1996-09-25 | Quadrant Holdings Cambridge | Co-amoxiclav dosage form |
US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
IL131201A (en) * | 1997-02-14 | 2005-06-19 | Smithkline Beecham Lab | Pharmaceutical formulations comprising amoxycillin and clavulanate |
US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
WO2000025751A2 (en) * | 1998-10-30 | 2000-05-11 | Fuisz International Ltd. | Improved amoxycillin and clavulanate composition |
US6177421B1 (en) | 1999-05-04 | 2001-01-23 | Fuisz International Ltd. | Amoxicillin and clavulanate composition |
IE990159A1 (en) * | 1999-02-26 | 2000-09-20 | Fuisz Internat Ltd | Storage Stable Amoxycillin and Clavulanate Suspension Composition. |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US6426342B2 (en) * | 1999-08-16 | 2002-07-30 | Revaax Pharmaceuticals, Llc | Use of β-lactamase inhibitors as neuroprotectants |
BR0013366A (pt) * | 1999-08-16 | 2002-07-23 | Revaax Pharmaceuticals Llc | Métodos para tratar um distúrbio comportamental, um paciente humano, doença de próstata, distúrbios de ansiedade e cognitivos em um paciente humano afligido com uma condição ou disposto ao desenvolvimento de uma condição distinguida pelo menos em parte pela concentração de glutamato extracelular anormal no cérebro ou em outro tecido nervoso, distúrbio comportamental nas espécies humana, canina, felina e equina e um paciente afligido com ou disposto a desenvolver uma doença compreendendo concentrações de glutamato anormalmente elevadas em tecido neuronal ou nìveis de naaladase elevados em tecido prostático e com esclerose múltipla e para realçar a função cognitiva, formulação farmacêutica e usos de um inibidor da atividade de peptidase de uma dipeptidase ácida ligada em alfa n-acetilada e de um composto de beta-lactama |
SI20411A (sl) * | 1999-12-22 | 2001-06-30 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Vodotopni praški za peroralno raztopino in njihova uporaba |
US6905016B2 (en) * | 2000-03-14 | 2005-06-14 | Noven Pharmaceuticals, Inc. | Packaging system for transdermal drug delivery systems |
AT412213B (de) * | 2000-05-30 | 2004-11-25 | Sandoz Ag | Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte |
EP1330236A2 (en) | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
US20060039967A1 (en) * | 2002-08-12 | 2006-02-23 | Motohiro Ohta | Amino acid-containing chewable |
US7341742B2 (en) * | 2002-09-30 | 2008-03-11 | L. Perrigo Company | Simethicone containing tablet composition and method |
MY147756A (en) * | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
DE102006007830A1 (de) * | 2006-02-17 | 2007-08-30 | Grünenthal GmbH | Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure |
US9458451B2 (en) | 2007-06-21 | 2016-10-04 | Gen-Probe Incorporated | Multi-channel optical measurement instrument |
JP2011500811A (ja) * | 2007-10-26 | 2011-01-06 | レクサン ファーマシューティカルズ インコーポレイテッド | クラブラン酸の医薬品製剤 |
JP2012525427A (ja) * | 2009-04-29 | 2012-10-22 | レクサン ファーマシューティカルズ インコーポレイテッド | 神経保護および神経変性疾患の治療のためのクラブラン酸塩製剤 |
TR200909787A2 (tr) | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar. |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) * | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3128135A (en) * | 1962-05-29 | 1964-04-07 | Anaconda Wire & Cable Co | Moisture-free package |
US3567085A (en) * | 1968-12-02 | 1971-03-02 | James G Flores | Neck-supported pill container |
IE41109B1 (en) * | 1974-04-20 | 1979-10-24 | Beecham Group Ltd | Novel -lactam antibiotic from streptomyces clavuligerus |
-
1977
- 1977-10-11 JO JO1977984A patent/JO984B1/en active
-
1978
- 1978-09-25 NZ NZ188497A patent/NZ188497A/xx unknown
- 1978-09-28 PT PT68600A patent/PT68600A/pt unknown
- 1978-09-28 IL IL55660A patent/IL55660A/xx unknown
- 1978-09-29 GB GB7838638A patent/GB2005538B/en not_active Expired
- 1978-10-03 BE BE190889A patent/BE870988A/xx not_active IP Right Cessation
- 1978-10-04 DE DE19782843318 patent/DE2843318A1/de not_active Ceased
- 1978-10-05 CA CA312,737A patent/CA1105385A/en not_active Expired
- 1978-10-06 FR FR7828600A patent/FR2405711A1/fr active Granted
- 1978-10-06 AU AU40506/78A patent/AU525089B2/en not_active Expired
- 1978-10-09 ZA ZA00785682A patent/ZA785682B/xx unknown
- 1978-10-09 IT IT51415/78A patent/IT1109273B/it active Protection Beyond IP Right Term
- 1978-10-10 SE SE7810591A patent/SE435899B/sv not_active IP Right Cessation
- 1978-10-10 PL PL21017478A patent/PL210174A1/xx unknown
- 1978-10-10 IE IE2019/78A patent/IE47450B1/en not_active IP Right Cessation
- 1978-10-10 MT MT836A patent/MTP836B/xx unknown
- 1978-10-10 NL NLAANVRAGE7810176,A patent/NL190631B/nl not_active Application Discontinuation
- 1978-10-11 CH CH1056278A patent/CH642258A5/de not_active IP Right Cessation
- 1978-10-11 JP JP12566178A patent/JPS5476831A/ja active Granted
-
1979
- 1979-03-05 US US06/017,365 patent/US4441609A/en not_active Expired - Lifetime
-
1980
- 1980-01-25 US US06/115,418 patent/US4301149A/en not_active Expired - Lifetime
-
1981
- 1981-12-17 SE SE8107592A patent/SE451668B/sv not_active IP Right Cessation
-
1985
- 1985-05-06 SG SG34985A patent/SG34985G/en unknown
- 1985-05-07 KE KE3525A patent/KE3525A/xx unknown
- 1985-09-26 HK HK737/85A patent/HK73785A/xx not_active IP Right Cessation
- 1985-12-30 MY MY996/85A patent/MY8500996A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IT7851415A0 (it) | 1978-10-09 |
US4441609A (en) | 1984-04-10 |
SE451668B (sv) | 1987-10-26 |
GB2005538A (en) | 1979-04-25 |
FR2405711A1 (fr) | 1979-05-11 |
IE47450B1 (en) | 1984-03-21 |
DE2843318A1 (de) | 1979-04-12 |
AU4050678A (en) | 1980-04-17 |
SE435899B (sv) | 1984-10-29 |
FR2405711B1 (nl) | 1982-10-29 |
SG34985G (en) | 1985-11-15 |
AU525089B2 (en) | 1982-10-21 |
PL210174A1 (nl) | 1980-08-11 |
SE8107592L (sv) | 1981-12-17 |
IL55660A (en) | 1981-09-13 |
CA1105385A (en) | 1981-07-21 |
NL7810176A (nl) | 1979-04-17 |
IE782019L (en) | 1979-04-11 |
JO984B1 (en) | 1979-12-01 |
CH642258A5 (de) | 1984-04-13 |
ZA785682B (en) | 1979-09-26 |
HK73785A (en) | 1985-10-04 |
SE7810591L (sv) | 1979-04-11 |
BE870988A (fr) | 1979-04-03 |
JPS6341886B2 (nl) | 1988-08-19 |
PT68600A (en) | 1978-10-01 |
KE3525A (en) | 1985-05-31 |
US4301149A (en) | 1981-11-17 |
JPS5476831A (en) | 1979-06-19 |
MY8500996A (en) | 1985-12-31 |
IL55660A0 (en) | 1978-12-17 |
MTP836B (en) | 1979-05-11 |
NZ188497A (en) | 1981-05-01 |
GB2005538B (en) | 1982-05-26 |
IT1109273B (it) | 1985-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL190631B (nl) | Farmaceutisch preparaat met antibacteriele werking dat amoxycilline en een zout van clavulanzuur bevat. | |
NL190554C (nl) | Cefalosporinederivaat, en farmaceutisch of veterinair preparaat met antibacteriële werking, dat dit cefalosporinederivaat bevat. | |
NL190664C (nl) | Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten. | |
NL183358C (nl) | Farmaceutisch preparaat, en daarin te gebruiken penicillaanzuur-derivaat met beta-lactamase-remmende werking. | |
NL192086B (nl) | Werkwijze ter bereiding van interferonen en werkwijze ter bereiding van een geneesmiddel dat interferonen bevat. | |
NL7603388A (nl) | In een menselijk of dierlijk lichaam in te plan- ten leiding. | |
NL190580C (nl) | Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten. | |
NL188850C (nl) | Werkwijze voor het bereiden van esters van moonzuur met antibacteriele werking, alsmede een farmaceutisch preparaat daarvan. | |
BE871584A (fr) | Preparations pharmaceutiques | |
NL192265B (nl) | Penemcarbonzuur-verbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
NL185622C (nl) | Farmaceutisch preparaat met antibacteriele werking, alsmede 7beta-acylamino-7alfa-methoxy-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur. | |
NL189561C (nl) | Gesubstitueerde cyclo-alkylideenmethylfenylazijnzuurverbindingen, alsmede een farmaceutisch preparaat, dat deze verbindingen bevat. | |
NL169591C (nl) | Werkwijze voor het bereiden van 2-4-(2-furoyl)-piperazine-1-yl-4-amino-6,7-dimethoxychinazoline.hydrochloride met bloeddrukverlagende werking en van een geneesmiddel met bloeddrukverlagende werking dat dit zout bevat. | |
NL146172B (nl) | Werkwijze voor de bereiding van een zout van pyridoxalfosforzuur en preparaat dat dit bevat. | |
BE883631A (fr) | Nouveau compose a activite antiepileptique et anticonvulsivante son procede de preparation et compositions pharmaceutiques le contenant | |
NL187746C (nl) | N2-arylsulfonyl-l-arginine-amiden, werkwijze ter bereiding daarvan, alsmede werkwijze ter bereiding van een farmaceutisch preparaat onder toepassing van een dergelijke verbinding en/of zout daarvan. | |
BE841424A (fr) | Medicament nouveau a activite antibacterienne | |
NL7805436A (nl) | Zout van p-hydroxyamandelzuur. | |
JPS5377073A (en) | Piperadine derivative compound and its production and medical drugs containing said compound | |
FR2300550A1 (fr) | Medicament antimicrobien | |
BE776788A (fr) | Preparations pharmaceutiques a activite anesthesique | |
IL58097A (en) | Pharmaceutical compositions comprising a clavulanic acid salt and a penicillin or cephalosporin salt | |
BE834334A (fr) | Preparations pharmaceutiques contenant un derive ou 2-amino-1,2-diphenylethanol | |
NL173054C (nl) | Werkwijze voor het bereiden van bis(carbamoylguanidino) verbindingen met antibacteriele werking en werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat dat werkzaam is tegen tandplaque. | |
NL179813C (nl) | Werkwijze voor het bereiden van een farmaceutisch preparaat met een anti-lipemische en perifere vaatverwijdende werking dat een zout van een p-chloorfenoxyalkaancarbonzuur bevat en werkwijze voor het bereiden van een dergelijk zout. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: BEECHAM GROUP PLC |
|
R1B | Notice of opposition during period of laying open | ||
R2B | Withdrawn after notice of opposition |